awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51431195-5C533B6F-CCDF-4735-A98A-FE5203CE9C9D
Q51431195-5C533B6F-CCDF-4735-A98A-FE5203CE9C9D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51431195-5C533B6F-CCDF-4735-A98A-FE5203CE9C9D
A next-generation anti-IgE monoclonal?
P2860
Q51431195-5C533B6F-CCDF-4735-A98A-FE5203CE9C9D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51431195-5C533B6F-CCDF-4735-A98A-FE5203CE9C9D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7b2166caafcccc367109bfdfd35d0f9ae36cca0b
P2860
Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects.